Mylan Inc. (MYL) Shares Bought by Advisory Services Network LLC
Advisory Services Network LLC raised its position in shares of Mylan Inc. (NASDAQ:MYL) by 43.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,537 shares of the company’s stock after buying an additional 770 shares during the period. Advisory Services Network LLC’s holdings in Mylan were worth $110,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of MYL. Prudential Financial Inc. boosted its stake in shares of Mylan by 2.0% in the first quarter. Prudential Financial Inc. now owns 504,859 shares of the company’s stock worth $23,400,000 after buying an additional 10,030 shares during the last quarter. C M Bidwell & Associates Ltd. purchased a new stake in shares of Mylan during the first quarter worth $2,656,000. Canada Pension Plan Investment Board boosted its stake in shares of Mylan by 85.3% in the first quarter. Canada Pension Plan Investment Board now owns 10,425 shares of the company’s stock worth $483,000 after buying an additional 4,800 shares during the last quarter. BB&T Securities LLC boosted its stake in shares of Mylan by 480.2% in the first quarter. BB&T Securities LLC now owns 84,693 shares of the company’s stock worth $3,925,000 after buying an additional 70,095 shares during the last quarter. Finally, Rafferty Asset Management LLC boosted its stake in shares of Mylan by 147.5% in the first quarter. Rafferty Asset Management LLC now owns 78,716 shares of the company’s stock worth $3,648,000 after buying an additional 46,911 shares during the last quarter. Institutional investors own 60.20% of the company’s stock.
Mylan Inc. (NASDAQ:MYL) traded down 3.21% during mid-day trading on Wednesday, reaching $37.08. The company’s stock had a trading volume of 6,249,527 shares. The firm has a market capitalization of $19.83 billion, a PE ratio of 23.47 and a beta of 1.14. The stock’s 50-day moving average is $40.72 and its 200-day moving average is $44.07. Mylan Inc. has a 12 month low of $35.58 and a 12 month high of $55.51.
Mylan (NASDAQ:MYL) last released its quarterly earnings data on Tuesday, August 9th. The company reported $1.16 EPS for the quarter, beating the consensus estimate of $1.13 by $0.03. Mylan had a return on equity of 23.22% and a net margin of 8.11%. The company had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.58 billion. During the same period last year, the company posted $0.91 earnings per share. The firm’s revenue was up 8.0% compared to the same quarter last year. On average, equities analysts anticipate that Mylan Inc. will post $4.95 EPS for the current year.
A number of equities research analysts have recently weighed in on MYL shares. Bank of America Corp. reaffirmed a “buy” rating and issued a $70.00 price objective on shares of Mylan in a research note on Wednesday, August 24th. JPMorgan Chase & Co. set a $52.00 price objective on Mylan and gave the company a “buy” rating in a research note on Tuesday, October 4th. Wells Fargo & Co. reissued a “market perform” rating and set a $44.00 target price on shares of Mylan in a research note on Thursday, August 25th. Goldman Sachs Group Inc. reissued a “conviction-buy” rating and set a $60.00 target price on shares of Mylan in a research note on Thursday, August 25th. Finally, Evercore ISI reissued a “hold” rating and set a $49.00 target price on shares of Mylan in a research note on Friday, August 26th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $53.49.
In other news, CEO Heather M. Bresch sold 100,200 shares of the firm’s stock in a transaction dated Tuesday, August 9th. The stock was sold at an average price of $50.00, for a total transaction of $5,010,000.00. Following the completion of the sale, the chief executive officer now directly owns 828,318 shares in the company, valued at $41,415,900. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.71% of the stock is owned by company insiders.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan Inc. (NASDAQ:MYL).
Receive News & Ratings for Mylan Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan Inc. and related companies with MarketBeat.com's FREE daily email newsletter.